Strides Pharma Science announced that its step down subsidiary Strides Pharma, Inc has on 29 January 2019 entered into an arrangement to acquire 100% stake in Vensun Pharmaceuticals, Inc.(Vensun), a US-based Generics Company. The board of directors of Strides have taken the same on record.
Vensun was founded in 2011 with an asset-light partner-driven business model to develop products for the US generics markets. It entered into a partnership with the erstwhile Shasun Pharmaceuticals for a range of difficult to develop products on a 50:50 profit share arrangement
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
